Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025 Next Post Zweig Breadth Thrust Dominates the Headlines – But What about an Exit Strategy? April 28, 2025 Related Posts Editor’s Picks: Gold Pulls Back, Experts Not Worried; Eyes on Fed Next Week May 4, 2025 Deep-Sea Crisis: Can the ISA Regain Control of the Deep Ocean? May 3, 2025 Ontario Tables Sweeping Bill to Restrict Foreign Access to Critical Minerals May 3, 2025